-
The Tale Of Merck’s Fake Medical Journal As Told At A Vioxx Trial In Australia
Drug Company Paid Scientific Publisher Elsevier To Produce What Was Essentially A Marketing Publication For Vioxx And Fosamax (Posted by Tom Lamb at DrugInjuryWatch.com) In early April 2009 we heard that there had been…
-
Off-Label Prescribing Of Drugs: An Explanation And Some Practical Guidance For Patients
Don't Be Afraid To Talk With Your Doctor About Any Medication You Are Prescribed — Especially If The Drug Is Being Used As A Treatment NOT Approved By FDA (Posted by Tom Lamb at…
-
April 2009 Update: Another Tysabri Patient Develops Serious Brain Infection PML
What Is Progressive Multifocal Leukoencephalopathy (PML), What Causes It, Why Is Tysabri Still On The Market? (Posted by Tom Lamb at DrugInjuryWatch.com) On April 17, 2009 we learned that another multiple-sclerosis patient using the…
-
Drug Interaction Prevention Is An Ongoing Process For Doctors And Patients
An Introduction Using Examples And Facts Relevant To Avoiding Drug-Drug Interaction Risks (Posted by Tom Lamb at DrugInjuryWatch.com) Patients who require multiple prescription drugs at one time, i.e., concomitant use, are sometimes placed at…
-
April 2009 FDA “Patient Safety News” Videos For Doctors Online
Covers Bowel Cleansing Agents Visicol and OsmoPrep, As Well As Methadone Overdoses, Ethex Generic Drug Recall, And Medication Errors (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA's Patient Safety News (PSN) is a series of…
-
A Timeline For The Psoriasis Drug Raptiva, From Product Launch In U.S. To Market Withdrawal
Raptiva Recalled in U.S. Due To Link With Fatal Brain Infection, Progressive Multifocal Leukoencephalopathy (PML) (Posted by Tom Lamb at DrugInjuryWatch.com) On April 8, 2009 Genentech Inc. — which was just acquired by Roche…
